Trial of RNActive®-Derived Prostate Cancer Vaccine in Metastatic Castrate-refractory Prostate Cancer
This study has been terminated.
(Follow up period after primary analysis was prematurely stopped because more mature data will not impact the study outcome)
First Posted: March 25, 2013
Last Update Posted: February 17, 2017
Information provided by (Responsible Party):